Transition From Research to Disclosure in Human Genetics
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Transition From Research to Disclosure in Human Genetics|
- Number of Participants Received Pre-test Genetic Counseling [ Time Frame: 10 Years ] [ Designated as safety issue: No ]
- Number of participants completing genetic testing for p53 [ Time Frame: Baseline to time of follow-up (2 weeks, 6, and 12 months) ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
|Study Start Date:||May 1999|
|Estimated Primary Completion Date:||May 2018 (Final data collection date for primary outcome measure)|
|Pre-Test Genetic Counseling + Genetic Sample||
Behavioral: Genetic Counseling
Genetic counseling conducted in person, by telephone with an M. D. Anderson Genetic Counselor, or with a local Genetic Counselor in conference with the M. D. Anderson Genetic Counselor.
Participants will receive pre-test genetic counseling in one of three ways: (1) in person at MD Anderson; (2) by telephone with an MD Anderson Genetic Counselor/study professional; (3) with a local Genetic Counselor in conference with the MD Anderson Genetic Counselor/study professional. After receiving pre-test genetic counseling, participants will be given the opportunity to schedule a submission of a small sample of blood (about 6 tablespoons) for genetic testing for p53. You may have this blood test repeated if there are any problems in the lab. The study doctor will discuss this with you.
Participants who submit a sample may choose to see a genetic counselor/study professional in person or schedule a phone conversation to receive the results of the genetic test. Genetic counseling may take place at MD Anderson at no cost. Participants may wish to have counseling close to their home, though they then are responsible for the cost of the counseling. If, after talking to the counselor/study professional, the participant wants to know the results of the test, he or she will be told. A participant will be given more counseling and advice on what other care might be needed and what other actions they should take.
The test results will be kept private. Names will not be used in computer records.
This is an investigational study. About 800 people will be offered genetic testing. This study is being performed only at MD Anderson.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00505466
|Contact: Louise C. Strong, MD||713-792-7555|
|United States, Texas|
|University of Texas MD Anderson Cancer Center||Recruiting|
|Houston, Texas, United States, 77030|
|Principal Investigator: Louise C. Strong, MD|
|Principal Investigator:||Louise C. Strong, MD||M.D. Anderson Cancer Center|